reviewed

Pharmaceutical: Tamsulosin (36C77024Q0292)

Waiver type - Procurement: Nonavailability

Agency: VETERANS AFFAIRS, DEPARTMENT OF (3600) • Product Service Code (PSC) : 6505 | Last Modified: 11/06/2024

Procurement Summary

VHA RPO-C/CMOP intends to procure Tamsulosin HCL for VA CMOPs. This procurement was solicited via 36C77024Q0292 as a competitive SDVOSB set-aside. This procurement is not subject to the Trade Agreements Act due to it being set aside for SDVOSBs. Tamsulosin HCL is an alpha1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia. This prescription is supplied to the CMOP, which provides direct mail order pharmacy services to Veterans and beneficiaries throughout the U.S. This is a onetime purchase with monthly deliveries for six (6) months.

Did / Will the solicitation include one of the standard BAA provisions announcing the agency’s intention to provide a price preference for domestic end products and construction material?

Yes

Was a sources sought or Request for Information issued?

OMB Determination

Consistent with Policy

Product

DRUGS AND BIOLOGICALS

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Date Submitted

11/04/2024

Procurement Instrument Identifier (PIID)

36C77024Q0292

Solicitation ID

36C77024Q0292

Procurement Stage

Post-solicitation

Expected Maximum Duration of the Proposed Waiver

0 - 6 months

Waiver Coverage

Individual Waiver

Funding Agency

VETERANS AFFAIRS, DEPARTMENT OF